[PDF][PDF] A living WHO guideline on drugs for covid-19

F Lamontagne, T Agoritsas, H Macdonald, YS Leo… - bmj, 2020 - zyicu.cn
The evidence base for therapeutics for covid-19 is evolving with numerous randomised
controlled trials (RCTs) recently completed and under way. This update adds new …

A living WHO guideline on drugs for covid-19

A Agarwal, BJ Hunt, M Stegemann, B Rochwerg… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published …

A living WHO guideline on drugs for covid-19

R Siemieniuk, B Rochwerg, T Agoritsas… - BMJ: British Medical …, 2020 - JSTOR
CLINICAL QUESTION What is the role of drug interventions in the treatment of patients with
covid-19? NEW RECOMMENDATION The latest version of this WHO living guidance …

Drug treatments for covid-19: living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Covid-19: what treatments are being investigated?

E Mahase - 2020 - bmj.com
With no current specific treatment for covid-19, the race is on to develop or repurpose drugs
to help end the epidemic. The World Health Organization has now launched the …

A living WHO guideline on drugs to prevent covid-19

F Lamontagne, M Stegemann, A Agarwal, T Agoritsas… - bmj, 2021 - bmj.com
Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …

Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19

H Naci, AS Kesselheim, JA Røttingen, G Salanti… - bmj, 2020 - bmj.com
Producing and using timely comparative evidence on drugs: lessons from clinical trials for
covid-19 Page 1 Producing and using timely comparative evidence on drugs: lessons from …

Colchicine for the treatment of COVID‐19

Cochrane Haematology Group… - Cochrane Database …, 1996 - cochranelibrary.com
Background The development of severe coronavirus disease 2019 (COVID‐19) and poor
clinical outcomes are associated with hyperinflammation and a complex dysregulation of the …

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis

HB Mehta, S Ehrhardt, TJ Moore, JB Segal… - BMJ open, 2020 - bmjopen.bmj.com
Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many
initiatives to identify safe and efficacious treatments, yet little is known regarding where early …

Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline

W Shah, T Hillman, ED Playford, L Hishmeh - bmj, 2021 - bmj.com
For a proportion of people covid-19 leads to long term effects that can have a significant
impact on quality of life. According to the Office for National Statistics, around one in five …